Correlation Between Ruentex Development and GeneFerm Biotechnology

Can any of the company-specific risk be diversified away by investing in both Ruentex Development and GeneFerm Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ruentex Development and GeneFerm Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ruentex Development Co and GeneFerm Biotechnology Co, you can compare the effects of market volatilities on Ruentex Development and GeneFerm Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ruentex Development with a short position of GeneFerm Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ruentex Development and GeneFerm Biotechnology.

Diversification Opportunities for Ruentex Development and GeneFerm Biotechnology

0.26

Correlation Coefficient

Ruentex Development  GeneFerm Biotechnology

Modest diversification

The 3 months correlation between Ruentex and GeneFerm is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Ruentex Development Co and GeneFerm Biotechnology Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneFerm Biotechnology and Ruentex Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ruentex Development Co are associated (or correlated) with GeneFerm Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneFerm Biotechnology has no effect on the direction of Ruentex Development i.e., Ruentex Development and GeneFerm Biotechnology go up and down completely randomly.

Pair Corralation between Ruentex Development and GeneFerm Biotechnology

Assuming the 90 days trading horizon Ruentex Development is expected to generate 148.7 times less return on investment than GeneFerm Biotechnology. But when comparing it to its historical volatility, Ruentex Development Co is 3.4 times less risky than GeneFerm Biotechnology. It trades about 0.01 of its potential returns per unit of risk. GeneFerm Biotechnology Co is currently generating about 0.46 of returns per unit of risk over similar time horizon. If you would invest  4,280  in GeneFerm Biotechnology Co on December 2, 2024 and sell it today you would earn a total of  1,670  from holding GeneFerm Biotechnology Co or generate 39.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Ruentex Development Co  vs.  GeneFerm Biotechnology Co

Ruentex Development

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ruentex Development Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

GeneFerm Biotechnology

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in GeneFerm Biotechnology Co are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, GeneFerm Biotechnology showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ruentex Development and GeneFerm Biotechnology

The main advantage of trading using opposite Ruentex Development and GeneFerm Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ruentex Development position performs unexpectedly, GeneFerm Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneFerm Biotechnology will offset losses from the drop in GeneFerm Biotechnology's long position.

The idea behind Ruentex Development Co and GeneFerm Biotechnology Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..